-
Zichen Zhao1，Jin Gu2,3,4,5（Peking University Wujieping Urology Center Peking University Shougang Hospital；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Center of Gastrointestinal Cancer Peking University Cancer Hospital & Institute；Peking-Tsinghua Center for Life Science Peking University International Cancer Center；Department of Gastrointestinal Surgery Peking University Shougang Hospital；Center for Precision Diagnosis and Treatment of Colorectal Cancer and Inflammatory Diseases）.Open surgery in the era of minimally invasive surgery[J].Chinese Journal of Cancer Research,2022,第1期
-
Zhitao Ying1，Ting He2，Shanzhao Jin2，Xiaopei Wang1，Wen Zheng1，Ningjing Lin1，Meifeng Tu1，Yan Xie1，Lingyan Ping1，Weiping Liu1，Lijuan Deng1，Yanping Ding2，Xuelian Hu2，Bing Bu3，Xin'an Lu2，Yuqin Song1，Jun Zhu1（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Lymphoma Peking University Cancer Hospital & Institute；Beijing Immunochina Pharmaceuticals Co. Ltd.；Department of Medical Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences）.A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma[J].Chinese Journal of Cancer Research,2022,第1期
-
Shichao Guo1，Guangchao Wang1，Zitong Zhao1，Dan Li1，Yongmei Song1，Qimin Zhan1,2（State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Laboratory of Molecular Oncology Peking University Cancer Hospital & Institute）.Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma[J].Chinese Journal of Cancer Research,2022,第1期
|